If a drug with high protein binding and a small molecular volume is administered intravenously, which consequence follows regarding its initial distribution?

💡 Explanation

Because the drug binds extensively to plasma proteins and has a small molecular volume, its distribution will be limited to the plasma. Therefore, it remains largely in the bloodstream rather than distributing widely into tissues, rather than being cleared quickly by the kidneys or penetrating into the brain.

• Why does drug X, administered intravenously, exhibit a longer half-life in a patient with chronic kidney disease compared to a healthy individual?
• Why does the lens curvature change dynamically during accommodation in the eye?
• Why does thyroxine (T4) to triiodothyronine (T3) conversion increase in peripheral tissues during chronic selenium deficiency?
• If a patient has chronic pain due to amplified nociceptor signals at the spinal cord, which pharmacological intervention would best reduce pain via descending modulation?
• If a dorsal horn neuron is continuously bombarded by substance P from C-fiber nociceptors, which consequence affecting descending modulation is most probable?
• When shift workers attempt to sleep during daylight hours, what process is suppressed, contributing to disrupted sleep patterns?